Clinical

Dataset Information

0

A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI


ABSTRACT: The purpose of this study is to test the safety of GI-4000 and see what effects (good and bad) it has against cancer over time. This study is also being done to measure the immune response to GI-4000. Study drug will be given in addition to a standard of care which is a standard therapy given to patients with your type of cancer (colon).

DISEASE(S): Colon Cancer,Colonic Neoplasms

PROVIDER: 2104326 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2015-07-31 | E-GEOD-59996 | biostudies-arrayexpress
2015-07-31 | GSE59996 | GEO
2013-09-01 | E-GEOD-47169 | biostudies-arrayexpress
| PRJEB7981 | ENA
2013-09-01 | GSE47169 | GEO
| PRJNA924021 | ENA
2019-08-30 | GSE119058 | GEO
2023-11-21 | GSE214792 | GEO
2023-11-21 | GSE214793 | GEO
2023-11-21 | GSE214791 | GEO